In Brief: The Chamberlain West Hollywood Hotel has changed hands, with Pebblebrook Hotel Trust finalizing the sale for a total of $43.5 million.
-
Image Credit Chamberlain West Hollywood Hotel
Pebblebrook Hotel Trust (NYSE: PEB) announced today that on May 27, 2026, it successfully completed the sale of the 115-room Chamberlain West Hollywood Hotel in Los Angeles, California for $43.5 million to a third party.
For the trailing twelve months ended April 30, 2026, the hotel generated earnings before interest, taxes, depreciation, and amortization (“EBITDA”) of $3.0 million and net operating income (“NOI”) of $2.6 million, assuming a capital reserve of 4.0% of total hotel revenues. The $43.5 million sales price equates to a 14.5x EBITDA multiple and a 5.9% NOI capitalization rate.
Pebblebrook expects to use the sale proceeds for general corporate purposes, with a primary focus on reducing outstanding net debt and preferred equity, opportunistically repurchasing the Company’s common shares, and supporting other high-return capital allocation priorities intended to enhance long-term shareholder value.
Including this transaction and the two strategic dispositions completed in the fourth quarter of 2025, Pebblebrook has completed approximately $160 million of asset sales at attractive private-market values, representing an aggregate 15.4x EBITDA multiple and 4.6% NOI capitalization rate. Since 2021, Pebblebrook has sold over $1.0 billion of properties, demonstrating its continued ability to monetize assets at private-market values and allocate capital toward debt reduction, accretive preferred and common share repurchases and other high-return uses.
Balance Sheet Impact
In connection with the sale, the Company accepted Pebblebrook preferred shares with an aggregate liquidation preference of $33.7 million as partial consideration from the buyer, at an agreed value of approximately $26.1 million. This enabled the Company to retire these preferred shares at a 23% discount to their liquidation preference, further reducing preferred equity outstanding to $720.6 million.
Since late 2025, Pebblebrook has continued its disciplined capital allocation strategy, using net property sales proceeds and free operating cash flow to strengthen its balance sheet and increase long-term per-share value. Over this period, the Company has reduced outstanding debt by nearly $160 million, retired preferred shares with an aggregate liquidation preference of $47 million at an average discount of 23%, and repurchased $62 million of common shares, representing 5.4 million shares at an average price of $11.51 per share. These actions have enhanced financial flexibility, reduced debt and preferred equity obligations, and increased long-term value per share.
Updated 2026 Outlook
To account for the property disposition, Pebblebrook has updated its prior second-quarter and full-year 2026 Outlook, previously provided on April 28, 2026. The Chamberlain has been removed from the Company’s Q2 through Q4 2026 Same-Property Hotel EBITDA and operating metrics, but its EBITDA from operations through the sale date will continue to be included in Adjusted EBITDAre.
|
The Company’s revised 2026 Outlook is as follows:
|
|||||||
|
|
2026 Outlook
|
|
Variance to Prior Outlook
|
||||
|
|
As of 5/28/26
|
|
Var to 4/28/26
|
||||
|
|
($ in millions, except per share data)
|
||||||
|
|
|
|
|
|
|
|
|
|
|
Low
|
|
High
|
|
Low
|
|
High
|
|
Net Income/(loss)
|
($8.2)
|
|
$3.8
|
|
($2.2)
|
|
($2.2)
|
|
Adjusted EBITDAre
|
$334.5
|
|
$346.5
|
|
($1.5)
|
|
($1.5)
|
|
Distribution to preferred shareholders and unit holders
|
$44.9
|
|
$44.9
|
|
($1.5)
|
|
($1.5)
|
|
Adjusted FFO
|
$184.0
|
|
$196.0
|
|
—
|
|
—
|
|
Adjusted FFO per diluted share
|
$1.60
|
|
$1.70
|
|
—
|
|
—
|
|
|
|
|
|
||||
|
This 2026 Outlook is based, in part, on the following estimates and assumptions:
|
|||||||
|
|
2026 Outlook
|
|
Variance to Prior Outlook
|
||||
|
|
As of 5/28/26
|
|
Var to 4/28/26
|
||||
|
($ in millions)
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
Low
|
|
High
|
|
Low
|
|
High
|
|
U.S. Hotel Industry RevPAR Growth Rate
|
0.0%
|
|
2.0%
|
|
—
|
|
—
|
|
Same-Property RevPAR variance vs. 2025
|
2.75%
|
|
4.75%
|
|
—
|
|
—
|
|
Same-Property Total RevPAR variance vs. 2025
|
3.0%
|
|
5.0%
|
|
—
|
|
—
|
|
Same-Property Total Revenue variance vs. 2025
|
3.1%
|
|
5.0%
|
|
—
|
|
—
|
|
Same-Property Total Expense variance vs. 2025
|
2.4%
|
|
3.8%
|
|
—
|
|
—
|
|
Same-Property Hotel EBITDA
|
$366.5
|
|
$378.5
|
|
($2.5)
|
|
($2.5)
|
|
The Company’s revised Q2 2026 Outlook is as follows:
|
|||||||
|
|
Q2 2026 Outlook
|
|
Variance to Prior Outlook
|
||||
|
|
As of 5/28/26
|
|
Var to 4/28/26
|
||||
|
($ in millions, except per share data)
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
Low
|
|
High
|
|
Low
|
|
High
|
|
Net Income
|
$18.8
|
|
$22.8
|
|
($0.7)
|
|
($0.7)
|
|
Adjusted EBITDAre
|
$106.0
|
|
$110.0
|
|
—
|
|
—
|
|
Distribution to preferred shareholders and unit holders
|
$11.1
|
|
$11.1
|
|
($0.5)
|
|
($0.5)
|
|
Adjusted FFO
|
$67.5
|
|
$71.5
|
|
$0.5
|
|
$0.5
|
|
Adjusted FFO per diluted share
|
$0.58
|
|
$0.62
|
|
—
|
|
—
|
|
|
|
|
|
|
|
|
|
|
This Q2 2026 Outlook is based, in part, on the following estimates and assumptions:
|
|||||||
|
|
Q2 2026 Outlook
|
|
Variance to Prior Outlook
|
||||
|
|
As of 5/28/26
|
|
Var to 4/28/26
|
||||
|
($ in millions, except RevPAR)
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
Low
|
|
High
|
|
Low
|
|
High
|
|
Same-Property RevPAR
|
$246
|
|
$251
|
|
$1
|
|
$1
|
|
Same-Property RevPAR variance vs. 2025
|
1.0%
|
|
3.0%
|
|
—
|
|
—
|
|
Same-Property Total RevPAR variance vs. 2025
|
1.0%
|
|
3.0%
|
|
—
|
|
—
|
|
|
|
|
|
|
—
|
|
—
|
|
Same-Property Total Revenue variance vs. 2025
|
1.0%
|
|
3.0%
|
|
—
|
|
—
|
|
Same-Property Total Expense variance vs. 2025
|
2.3%
|
|
3.8%
|
|
—
|
|
—
|
|
|
|
|
|
|
|
|
|
|
Same-Property Hotel EBITDA
|
$112.7
|
|
$116.7
|
|
($0.8)
|
|
($0.8)
|


